Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Tibet Pharmaceuticals
(OTCEM:TBET)
Intraday
$~0
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$~0
0
[0.00%]
At close: Dec 22
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Tibet Pharmaceuticals Stock (OTC:TBET)
Tibet Pharmaceuticals Stock (OTC: TBET)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, March 08, 2012
Benzinga's Microcap Movers for Wednesday March 7, 2012
Benzinga
-
Mar 8, 2012, 7:29AM
Thursday, March 01, 2012
Tibet Pharmaceuticals, Inc. Announces Receipt of Non-Binding "Going Private" Proposal at $3.00 Per Share
Benzinga
-
Mar 1, 2012, 8:54AM
Monday, February 27, 2012
Benzinga's M&A Chatter for Monday February 27, 2012
Benzinga
-
Feb 27, 2012, 5:37PM
Tibet Pharmaceuticals Announces Intent to Go Private
Benzinga
-
Feb 27, 2012, 8:02AM
Tuesday, January 31, 2012
Tibet Pharmaceuticals Signs Letter of Intent to Cooperate With Anhui Taihe Pharmaceutical Group
Benzinga
-
Jan 31, 2012, 4:05PM
Tuesday, October 18, 2011
Tibet Pharmaceuticals Announces Appointment of Sherb & Co., LLP as New Independent Auditor
Benzinga
-
Oct 18, 2011, 9:01AM
Tuesday, September 20, 2011
Morning Market Movers
Benzinga
-
Sep 20, 2011, 9:45AM
Tuesday, September 13, 2011
NASDAQ Scheduled Resumption in Tibet Pharmaceuticals for 1:30 PM
Benzinga
-
Sep 13, 2011, 12:59PM
Monday, September 12, 2011
Tibet Pharmaceuticals Announces Search for New Auditor Upon Resignation of ACSB
Benzinga
-
Sep 12, 2011, 4:15PM
Tibet Pharma Halted
Benzinga
-
Sep 12, 2011, 3:41PM
Wednesday, June 29, 2011
Morning Market Losers
Benzinga
-
Jun 29, 2011, 9:57AM
Friday, June 10, 2011
Tibet Pharmaceuticals Announces New CEO
Benzinga
-
Jun 10, 2011, 4:05PM
Tuesday, April 19, 2011
Murphy Analytics Initiates Research Coverage on Tibet Pharmaceuticals (TBET)
Benzinga
-
Apr 19, 2011, 4:28PM
Monday, January 24, 2011
Tibet Pharmaceuticals Announces Closing of IPO
Benzinga
-
Jan 24, 2011, 4:35PM
